{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:05:22Z","timestamp":1761401122404},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[1999,4,23]],"date-time":"1999-04-23T00:00:00Z","timestamp":924825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1038\/sj.bjc.6690408","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T14:24:08Z","timestamp":1032272648000},"page":"670-675","source":"Crossref","is-referenced-by-count":8,"title":["Loss of functional pRB is not a ubiquitous feature of B-cell malignancies"],"prefix":"10.1038","volume":"80","author":[{"given":"A J","family":"Sinclair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,4,23]]},"reference":[{"key":"BF6690408_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ijc.2910610120","volume":"61","author":"L Aagaard","year":"1995","unstructured":"Aagaard, L., Lukas, J., Bartkova, J., Kjerulff, A. A., Strauss, M. & Bartek, J. (1995). Aberrations of p16INK4a and retinoblastoma tumour-suppressor genes occur in distinct subsets of human cancer cell lines. Int J Cancer 61: 115\u2013120.","journal-title":"Int J Cancer"},{"key":"BF6690408_CR2","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/j.1460-2075.1995.tb07124.x","volume":"14","author":"MJ Allday","year":"1995","unstructured":"Allday, M. J., Sinclair, A. J., Crawford, D. H. & Farrell, P. J. (1995). Epstein-Barr virus efficiently immortalizes human B-cells without neutralising the function of p53. EMBO J 14: 1382\u20131391.","journal-title":"EMBO J"},{"key":"BF6690408_CR3","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1093\/emboj\/16.17.5322","volume":"16","author":"K Alevizopoulos","year":"1997","unstructured":"Alevizopoulos, K., Vlavh, J., Hennecke, S. & Amati, B. (1997). Cyclin E and c-myc proteins promote cell proliferation in the presence of p16INK4a and hypophosphorylated retinoblastoma family proteins. EMBO J 16: 5322\u20135333.","journal-title":"EMBO J"},{"key":"BF6690408_CR4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4049\/jimmunol.155.3.1047","volume":"155","author":"L Arvanitakis","year":"1995","unstructured":"Arvanitakis, L., Yaseen, N. & Sharma, S. (1995). Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-\u03b2-1-mediated growth-inhibition in EBV-positive B-cells. J Immunol 155: 1047\u20131056.","journal-title":"J Immunol"},{"key":"BF6690408_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","volume":"16","author":"PM Banks","year":"1992","unstructured":"Banks, P. M., Chan, J., Cleary, M. L., Delsol, G., Dewolfpeeters, C., Gatter, K., Grogan, T. M., Harris, N. L., Isaacson, P. G., Jaffe, E. S., Mason, D., Pileri, S., Ralfkiaer, E., Stein, H. & Warnke, R. A. (1992). Mantle cell lymphoma \u2013 a proposal for unification of morphological, immunological, and molecular-data. Am J Surg Pathol 16: 637\u2013640.","journal-title":"Am J Surg Pathol"},{"key":"BF6690408_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0955-0674(96)80081-0","volume":"8","author":"J Bartek","year":"1996","unstructured":"Bartek, J., Bartekova, J. & Lukas, J. (1996). The retinoblastoma protein pathway and the restriction point. Curr Opin Cell Biol 8: 805\u20138114.","journal-title":"Curr Opin Cell Biol"},{"key":"BF6690408_CR7","first-page":"5475","volume":"56","author":"J Bartekova","year":"1996","unstructured":"Bartekova, J., Lukas, J., Guldberg, P., Alsner, J., Kirkin, A. F., Zeuthen, J. & Bartek, J. (1996). The p16-cyclin-D cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res 56: 5475\u20135483.","journal-title":"Cancer Res"},{"key":"BF6690408_CR8","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/sj.onc.1202016","volume":"17","author":"J Bartekova","year":"1998","unstructured":"Bartekova, J., Lukas, J., Strauss, M. & Bartek, J. (1998). Cyclin D3: requirement for G1\/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 17: 1027\u20131037.","journal-title":"Oncogene"},{"key":"BF6690408_CR9","first-page":"71","volume":"9","author":"S Bates","year":"1994","unstructured":"Bates, S., Bonetta, L., MacAllan, D., Parry, D., Holder, A., Dickson, C. & Peters, G. (1994). CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene 9: 71\u201379.","journal-title":"Oncogene"},{"key":"BF6690408_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ijc.2910190105","volume":"19","author":"H Ben-bassat","year":"1977","unstructured":"Ben-bassat, H., Goldblum, N., Mitrani, S., Goldblum, T., Yoffey, J. M., Cohey, M. M., Bentwich, Z., Ramot, B., Klein, E. & Klein, G. (1977). Establishment in continuous culture of a new type of lymphocyte from a Burkitt-like malignant lymphoma (DG-75). Int J Cancer 19: 27\u201333.","journal-title":"Int J Cancer"},{"key":"BF6690408_CR11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/0092-8674(89)90508-4","volume":"58","author":"K Buchkovich","year":"1989","unstructured":"Buchkovich, K., Duffy, L. A. & Harlow, E. (1989). The retinoblastoma protein is phosphorylated during specific phases of the cell-cycle. Cell 58: 1097\u20131105.","journal-title":"Cell"},{"key":"BF6690408_CR12","first-page":"1413","volume":"13","author":"EJ Cannell","year":"1996","unstructured":"Cannell, E. J., Farrell, P. J. & Sinclair, A. J. (1996). EBV exploits the normal cell pathway to regulate pRb activity during the immortalisation of primary B-cells. Oncogene 13: 1413\u20131421.","journal-title":"Oncogene"},{"key":"BF6690408_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ijc.2910160114","volume":"16","author":"GB Clements","year":"1975","unstructured":"Clements, G. B., Klein, G. & Povey, S. (1975). Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without EBV DNA. Int J Cancer 16: 125\u2013133.","journal-title":"Int J Cancer"},{"key":"BF6690408_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0165-4608(92)90314-X","volume":"64","author":"JK Cowell","year":"1992","unstructured":"Cowell, J. K. & Hogg, A. (1992). Genetics and cytogenetics of retinoblastoma. Cancer Genet Cytogenet 64: 11\u201315.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF6690408_CR15","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1128\/MCB.10.11.5772","volume":"10","author":"L Diller","year":"1990","unstructured":"Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., Vogelstein, B. & Friend, S. H. (1990). p53 functions as a cell-cycle control protein in osteosarcomas. Mol Cell Biol 10: 5772\u20135781.","journal-title":"Mol Cell Biol"},{"key":"BF6690408_CR16","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1002\/j.1460-2075.1991.tb07837.x","volume":"10","author":"PJ Farrell","year":"1991","unstructured":"Farrell, P. J., Allan, G. J., Shanahan, F., Vousden, K. H. & Crook, T. (1991). p53 is frequently mutated in Burkitt\u2019s lymphoma cell lines. EMBO J 10: 2879\u20132887.","journal-title":"EMBO J"},{"key":"BF6690408_CR17","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1099\/0022-1317-71-7-1481","volume":"71","author":"CD Gregory","year":"1990","unstructured":"Gregory, C. D., Rowe, M. & Rickinson, A. B. (1990). Different Epstein\u2013Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt\u2019s lymphoma cell line. J Gen Virol 71: 1481\u20131495.","journal-title":"J Gen Virol"},{"key":"BF6690408_CR18","first-page":"68","volume":"68","author":"M Hall","year":"1996","unstructured":"Hall, M. & Peters, G. (1996). Genetic alterations of cyclins, cyclin dependent kinases and cdk inhibitors in human cancer. Adv Cancer Res 68: 68\u2013108.","journal-title":"Adv Cancer Res"},{"key":"BF6690408_CR19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1128\/MCB.16.3.859","volume":"16","author":"E Hara","year":"1996","unstructured":"Hara, E., Smith, R., Parry, D., Tahara, H., Steven, S. & Peters, G. (1996). Regulation of p16(CDKN2) expression and its implications for cell immortalization and senescence. Mol Cell Biol 16: 859\u2013867.","journal-title":"Mol Cell Biol"},{"key":"BF6690408_CR20","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J., Cleary, M. L., Delsol, G., Dewolfpeeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P. G., Knowles, D. M., Mason, D. Y., Mullerhermelink, H. K., Pileri, S. A., Piris, M. A., Ralfkiaer, E. & Warnke, R. A. (1994). A revised European\u2013American classification of lymphoid neoplasms \u2013 a proposal from the international lymphoma study-group. Blood 84: 1361\u20131392.","journal-title":"Blood"},{"key":"BF6690408_CR21","first-page":"4833","volume":"55","author":"J He","year":"1995","unstructured":"He, J., Olson, J. J. & James, C. D. (1995). Lack of p16(INK4) or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell-lines. Cancer Res 55: 4833\u20134836.","journal-title":"Cancer Res"},{"key":"BF6690408_CR22","first-page":"4525","volume":"55","author":"JG Herman","year":"1995","unstructured":"Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J., Davidson, N. E., Sidransky, D. & Baylin, S. B. (1995). Inactivation of the CDKN2\/p16\/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525\u20134530.","journal-title":"Cancer Res"},{"key":"BF6690408_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1432-1033.1997.t01-2-00581.x","volume":"246","author":"S Herwig","year":"1997","unstructured":"Herwig, S. & Strauss, M. (1997). The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 246: 581\u2013601.","journal-title":"Eur J Biochem"},{"key":"BF6690408_CR24","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/JVI.1.5.1045-1051.1967","volume":"1","author":"Y Hinuma","year":"1967","unstructured":"Hinuma, Y., Konn, M., Yamaguchi, J., Wudarski, D., Blakeslee, J. & Grace, J. (1967). Immunofluorescence and herpes type virus particles in the P3HR-1 Burkitt lymphoma gene. J Virol 1: 1045\u20131051.","journal-title":"J Virol"},{"key":"BF6690408_CR25","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/eji.1830230948","volume":"23","author":"MJ Holder","year":"1993","unstructured":"Holder, M. J., Wang, H., Milner, A. E., Casamayor, M., Armitage, R., Spriggs, M. K., Fanslow, W. C., MacLennan, I. C., Gregory, C. D. & Gordon, J. (1993). Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bc1-2 induction. Eur J Immunol 23: 2368\u20132371.","journal-title":"Eur J Immunol"},{"key":"BF6690408_CR26","first-page":"4784","volume":"55","author":"M Hollyoake","year":"1995","unstructured":"Hollyoake, M., St\u00fchler, A., Farrell, P., Gordon, J. & Sinclair, A. (1995). The normal cell cycle activation programme is exploited during the infection of quiescent B-lymphocytes by Epstein-Barr virus. Cancer Res 55: 4784\u20134787.","journal-title":"Cancer Res"},{"key":"BF6690408_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1349-7006.1997.tb00371.x","volume":"88","author":"N Itoh","year":"1997","unstructured":"Itoh, N., Kakehi, Y., Akao, T., Kinoshita, H., Okada, Y. & Yoshida, O. (1997). Concomitant presence of p16 cyclin-dependent kinase 4 and cyclin D cyclin-dependent kinase 4 complexes in LNCaP prostatic cancer cell line. Jpn J Cancer Res 88: 229\u2013233.","journal-title":"Jpn J Cancer Res"},{"key":"BF6690408_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ijc.2910630214","volume":"63","author":"MJ Kelley","year":"1995","unstructured":"Kelley, M. J., Otterson, G. A., Kaye, F. J., Popescu, N. C., Johnson, B. E. & Dipaolo, J. A. (1995). CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell-lines. Int J Cancer 63: 226\u2013230.","journal-title":"Int J Cancer"},{"key":"BF6690408_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/j.1460-2075.1995.tb06978.x","volume":"14","author":"B Kempkes","year":"1995","unstructured":"Kempkes, B., Spitkovsky, D., Jansen-Durr, P., Ellwart, J. W., Kremmer, E., Delecluse, H. J., Rottenberger, C., Bornkamm, G. W. & Hammerschmidt, W. (1995). B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J 14: 88\u201396.","journal-title":"EMBO J"},{"key":"BF6690408_CR30","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1073\/pnas.93.9.4350","volume":"93","author":"SN Khleif","year":"1996","unstructured":"Khleif, S. N., Degregori, J., Yee, C. L., Otterson, G. A., Kaye, F. J., Nevins, J. R. & Howley, P. M. (1996). Inhibition of cyclin D-cdk4\/cdk6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 93: 4350\u20134354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6690408_CR31","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/JVI.36.2.506-518.1980","volume":"36","author":"W King","year":"1980","unstructured":"King, W., Thomas-Powell, A. L., Raab-Traub, N., Hawke, M. & Kieff, E. (1980). Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line. J Virol 36: 506\u2013518.","journal-title":"J Virol"},{"key":"BF6690408_CR32","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.4049\/jimmunol.130.4.1985","volume":"130","author":"G Klein","year":"1983","unstructured":"Klein, G., Ehlin-Hendrikson, B. & Schlossman, S. (1983). Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains. J Immunol 130: 1985\u20131989.","journal-title":"J Immunol"},{"key":"BF6690408_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000149930","volume":"5","author":"G Klein","year":"1975","unstructured":"Klein, G., Giovanella, B., Westman, A., Stehlin, J. & Mumford, D. (1975). An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5: 319\u2013334.","journal-title":"Intervirology"},{"key":"BF6690408_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/375506a0","volume":"375","author":"J Koh","year":"1995","unstructured":"Koh, J., Enders, G. H., Dynlacht, B. & Harlow, E. (1995). Tumour derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature 375: 506\u2013509.","journal-title":"Nature"},{"key":"BF6690408_CR35","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/jnci\/87.24.1870","volume":"87","author":"RA Kratzke","year":"1995","unstructured":"Kratzke, R. A., Otterson, G. A., Lincoln, C. E., Ewing, S., Oie, H., Geradts, J. & Kaye, F. J. (1995). Immunohistochemical analysis of the p16(ink4) cyclin-dependent kinase inhibitor in malignant mesothelioma. J Natl Cancer Inst 87: 1870\u20131875.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690408_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/387422a0","volume":"387","author":"G Leone","year":"1997","unstructured":"Leone, G., DeGregori, J., Sears, R., Jakoi, L. & Nevins, J. (1997). Myc and ras collaborate in inducing accumulation of active cyclin E\/cdk2 and E2F. Nature 387: 422\u2013426.","journal-title":"Nature"},{"key":"BF6690408_CR37","first-page":"6078","volume":"54","author":"Y Li","year":"1994","unstructured":"Li, Y., Nichols, M. A., Shay, J. W. & Xiong, Y. (1994). Transcriptional repression of the D-type cyclin dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078\u20136082.","journal-title":"Cancer Res"},{"key":"BF6690408_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0092-8674(89)90983-5","volume":"56","author":"JW Ludlow","year":"1989","unstructured":"Ludlow, J. W., Decaprio, J. A., Huang, C. M., Lee, W. H., Paucha, E. & Livingston, D. M. (1989). SV40 large T-antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene-product family. Cell 56: 57\u201365.","journal-title":"Cell"},{"key":"BF6690408_CR39","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1101\/gad.11.11.1479","volume":"11","author":"J Lukas","year":"1997","unstructured":"Lukas, J., Herzinger, T., Hansen, K., Moroni, M. C., Resnitzky, D., Helin, K., Reed, S. I. & Bartek, J. (1997). Cyclin E-induced S-phase without activation of the pRb\/E2F pathway. Genes Dev 11: 1479\u20131492.","journal-title":"Genes Dev"},{"key":"BF6690408_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/375503a0","volume":"375","author":"J Lukas","year":"1995","unstructured":"Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartokova, J., Strauss, M., Peters, G. & Bartek, J. (1995a). Retinoblastoma-protein dependent cell cycle inhibition by the tumour suppressor p16. Nature 375: 503\u2013506.","journal-title":"Nature"},{"key":"BF6690408_CR41","first-page":"2125","volume":"10","author":"J Lukas","year":"1995","unstructured":"Lukas, J., Bartokova, J., Welcker, M., Peterson, O. W., Peters, G., Strauss, M. & Bartek, J. (1995b). Cyclin D2 is a moderately oscillating nucleoprotein required for g1 phase progression in specific cell types. Oncogene 10: 2125\u20132134.","journal-title":"Oncogene"},{"key":"BF6690408_CR42","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.V87.3.1147.bloodjournal8731147","volume":"87","author":"I MacDonald","year":"1996","unstructured":"MacDonald, I., Wang, H., Grand, R., Armitage, R., Fanslow, W., Gregory, C. & Gordon, J. (1996). Transforming growth factor \u03b21 co-operates with anti-immunoglobulin for the induction of apoptosis in group I Burkitt\u2019s lymphomas cell lines. Blood 87: 1147\u20131154.","journal-title":"Blood"},{"key":"BF6690408_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/path.1711690404","volume":"169","author":"JC Martinez","year":"1993","unstructured":"Martinez, J. C., Piris, M. A., Sanchezbeato, M., Villuendas, R., Orradre, J. L., Algara, P., Sanchezverde, L. & Martinez, P. (1993). Retinoblastoma (Rb) gene-product expression in lymphomas \u2013 correlation with Ki67 growth fraction. J Pathol 169: 405\u2013412.","journal-title":"J Pathol"},{"key":"BF6690408_CR44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0014-4827(75)90404-8","volume":"92","author":"J Menezes","year":"1975","unstructured":"Menezes, J., Leibold, W. & Klein, G. (1975). Biological differences between Epstein-Barr virus (EBV) with regard to lymphocyte transforming ability, superinfection, and interference. Exp Cell Res 92: 431\u2013443.","journal-title":"Exp Cell Res"},{"key":"BF6690408_CR45","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nm0795-686","volume":"1","author":"A Merlo","year":"1995","unstructured":"Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B. & Sidransky, D. (1995). 5\u2032 CpG island methylation is associated with transcriptional silencing of the tumor-suppressor p16\/CDKN2\/MTS1 in human cancers. Nat Med 1: 686\u2013692.","journal-title":"Nat Med"},{"key":"BF6690408_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0959-437X(98)80057-9","volume":"8","author":"S Mittnacht","year":"1998","unstructured":"Mittnacht, S. (1998). Control of pRb phosphorylation. Curr Opin Genet Dev 8: 21\u201327.","journal-title":"Curr Opin Genet Dev"},{"key":"BF6690408_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/371072a0","volume":"371","author":"SD Morganbesser","year":"1994","unstructured":"Morganbesser, S. D., Williams, B. O., Jacks, T. & DePinho, R. A. (1994). p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72\u201374.","journal-title":"Nature"},{"key":"BF6690408_CR48","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ijc.2910630420","volume":"63","author":"EA Musgrove","year":"1995","unstructured":"Musgrove, E. A., Lilischkis, R., Cornish, A. L., Lee, C., Setlur, V., Seshadri, R. & Sutherland, R. L. (1995). Expression of the cyclin-dependent kinase inhibitors p16(INK4), p15(INK4b) and p21(WAF1\/CIP1) in human breast-cancer. Int J Cancer 63: 584\u2013591.","journal-title":"Int J Cancer"},{"key":"BF6690408_CR49","first-page":"3375","volume":"9","author":"GA Otterson","year":"1994","unstructured":"Otterson, G. A., Kratzke, R. A., Coxon, A., Kim, Y. W. & Kaye, F. J. (1994). Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9: 3375\u20133378.","journal-title":"Oncogene"},{"key":"BF6690408_CR50","first-page":"1211","volume":"11","author":"GA Otterson","year":"1995","unstructured":"Otterson, G. A., Khleif, S. N., Chen, W. D., Coxon, A. B. & Kaye, F. J. (1995). Cdkn2 gene silencing in lung-cancer by dna hypermethylation and kinetics of p16(ink4) protein induction by 5-aza 2\u00b4 deoxycytidine. Oncogene 11: 1211\u20131216.","journal-title":"Oncogene"},{"key":"BF6690408_CR51","first-page":"351","volume":"27","author":"I Palmero","year":"1996","unstructured":"Palmero, I. & Peters, G. (1996). Perturbation of cell-cycle regulators in human cancer. Cancer Surv 27: 351\u2013367.","journal-title":"Cancer Surv"},{"key":"BF6690408_CR52","first-page":"1049","volume":"8","author":"I Palmero","year":"1993","unstructured":"Palmero, I., Holder, A., Sinclair, A. J., Dickson, C. & Peters, G. (1993). Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene 8: 1049\u20131054.","journal-title":"Oncogene"},{"key":"BF6690408_CR53","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1101\/gad.8.11.1285","volume":"8","author":"H Pan","year":"1994","unstructured":"Pan, H. & Griep, A. E. (1994). Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumour suppressor gene function in development. Gene Dev 8: 1285\u20131299.","journal-title":"Gene Dev"},{"key":"BF6690408_CR54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/j.1460-2075.1995.tb07026.x","volume":"14","author":"D Parry","year":"1995","unstructured":"Parry, D., Bates, S., Mann, D. J. & Peters, G. (1995). Lack of cyclin D-cdk complexes in Rb-negative cells correlates with high levels of p16 INK4\/MTS-1 tumour suppressor gene product. EMBO J 14: 503\u2013511.","journal-title":"EMBO J"},{"key":"BF6690408_CR55","first-page":"1723","volume":"7","author":"K Pokrovskaja","year":"1996","unstructured":"Pokrovskaja, K., Ehlinhenriksson, B., Bartkova, J., Bartek, J., Scuderi, R., Szekely, L., Wiman, K. G. & Klein, G. (1996). Phenotype-related differences in the expression of D-type cyclins in human B-cell-derived lines. Cell Growth Differ 7: 1723\u20131732.","journal-title":"Cell Growth Differ"},{"key":"BF6690408_CR56","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/ijc.2910020505","volume":"2","author":"J Ponten","year":"1967","unstructured":"Ponten, J. & Saksela, E. (1967). Spontaneous lymphoblast transformation of long-term cell cultures from human malignant lymphoma. Int J Cancer 2: 434\u2013447.","journal-title":"Int J Cancer"},{"key":"BF6690408_CR57","first-page":"3287","volume-title":"Fields Virology","author":"AB Rickinson","year":"1996","unstructured":"Rickinson, A. B. & Keiff, E. (1996). Epstein-Barr virus. In Fields Virology, Fields BN, Knipe DM, Howley PM (eds), pp. 3287\u20132446. Lippencot-Raven: Philadelphia"},{"key":"BF6690408_CR58","doi-asserted-by":"crossref","unstructured":"Ruas, M. & Peters, G. (1998). The p16INK4a\/CDKN2A tumour suppressor and its relatives. Biochem Biophys Acta (in press)","DOI":"10.1016\/S0304-419X(98)00017-1"},{"key":"BF6690408_CR59","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0955-0674(96)80004-4","volume":"8","author":"I Sanchez","year":"1996","unstructured":"Sanchez, I. & Dynlacht, B. D. (1996). Transcriptional control of the cell-cycle. Curr Opin Cell Biol 8: 318\u2013324.","journal-title":"Curr Opin Cell Biol"},{"key":"BF6690408_CR60","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1073\/pnas.88.13.5523","volume":"88","author":"M Scheffner","year":"1991","unstructured":"Scheffner, M., M\u00fcnger, K., Byrne, J. C. & Howley, P. M. (1991). The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88: 5523\u20135527.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6690408_CR61","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/366704a0","volume":"366","author":"M Serrano","year":"1993","unstructured":"Serrano, M., Hannon, G. J. & Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4. Nature 366: 704\u2013707.","journal-title":"Nature"},{"key":"BF6690408_CR62","first-page":"505","volume":"55","author":"GI Shapiro","year":"1995","unstructured":"Shapiro, G. I., Edwards, C. D., Kobzik, L., Godleski, J., Richards, W., Sugarbaker, D. J. & Rollins, B. J. (1995a). Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res 55: 505\u2013509.","journal-title":"Cancer Res"},{"key":"BF6690408_CR63","first-page":"6200","volume":"55","author":"GI Shapiro","year":"1995","unstructured":"Shapiro, G. I., Park, J. E., Edwards, C. D., Mao, L., Merlo, A., Sidransky, D., Ewen, M. E. & Rollins, B. J. (1995b). Multiple mechanisms of p16(INK4a) inactivation in non-small-cell lung-cancer cell-lines. Cancer Res 55: 6200\u20136209.","journal-title":"Cancer Res"},{"key":"BF6690408_CR64","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","volume":"9","author":"CJ Sherr","year":"1995","unstructured":"Sherr, C. J. & Roberts, J. M. (1995). Inhibitors of mammalian G(1) cyclin-dependent kinases. Genes Dev 9: 1149\u20131163.","journal-title":"Genes Dev"},{"key":"BF6690408_CR65","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1200\/JCO.1993.11.4.802","volume":"11","author":"RA Shivdasani","year":"1993","unstructured":"Shivdasani, R. A., Hess, J. L., Skarin, A. T. & Pinkus, G. S. (1993). Intermediate lymphocytic lymphoma \u2013 clinical and pathological features of a recently characterized subtype of non-Hodgkins-lymphoma. J Clin Oncol 11: 802\u2013811.","journal-title":"J Clin Oncol"},{"key":"BF6690408_CR66","first-page":"89","volume-title":"Methods in Molecular Genetics","author":"AJ Sinclair","year":"1995","unstructured":"Sinclair, A. J. & Farrell, P. J. (1995). Methods to study Epstein-Barr virus and p53 status in human cells. In Methods in Molecular Genetics, Aldolph KW (ed), pp. 89\u2013100. Academic Press: Orlando"},{"key":"BF6690408_CR67","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/viro.1994.1132","volume":"199","author":"AJ Sinclair","year":"1993","unstructured":"Sinclair, A. J., Jacquemin, M. G., Brooks, L., Shanahan, F., Brimmell, M., Rowe, M. & Farrell, P. J. (1993). Reduced signal transduction through glucocorticoid receptor in Burkitt\u2019s lymphoma cell lines. Virology 199: 339\u2013353.","journal-title":"Virology"},{"key":"BF6690408_CR68","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1002\/j.1460-2075.1994.tb06634.x","volume":"13","author":"AJ Sinclair","year":"1994","unstructured":"Sinclair, A. J., Palmero, I., Peters, G. & Farrell, P. J. (1994). EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein\u2013Barr virus. EMBO J 13: 3321\u20133328.","journal-title":"EMBO J"},{"key":"BF6690408_CR69","first-page":"461","volume":"13","author":"AJ Sinclair","year":"1998","unstructured":"Sinclair, A. J., Fenton, M. & Delikat, D. (1998). Interactions between EBV and the cell cycle control machinery. Histol Histopathol 13: 461\u2013467.","journal-title":"Histol Histopathol"},{"key":"BF6690408_CR70","first-page":"1869","volume":"10","author":"L Szekely","year":"1995","unstructured":"Szekely, L., Pokrovskaja, K., Jiang, W-Q, Selivanova, G., L\u00f6wbeer, M., Ringertz, N., Wiman, K. G. & Klein, G. (1995). Resting B-cells, EBV-infected blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns. Oncogene 10: 1869\u20131874.","journal-title":"Oncogene"},{"key":"BF6690408_CR71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ijc.2910330106","volume":"33","author":"K Takada","year":"1984","unstructured":"Takada, K. (1984). Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 33: 27\u201332.","journal-title":"Int J Cancer"},{"key":"BF6690408_CR72","first-page":"5816","volume":"54","author":"SW Tam","year":"1994","unstructured":"Tam, S. W., Shay, J. W. & Pagano, M. (1994). Differential expression and cell cycle regulation of the cyclin dependent kinases 4 inhibitor p16. Cancer Res 54: 5816\u20135820.","journal-title":"Cancer Res"},{"key":"BF6690408_CR73","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1073\/pnas.88.8.3033","volume":"88","author":"DJ Templeton","year":"1991","unstructured":"Templeton, D. J., Park, S. H., Lanier, L. & Weinberg, R. A. (1991). Nonfunctional mutants of the retinoblastoma protein are characterised by defects in phosphorylation, viral oncoprotein association and nuclear tethering. Proc Natl Acad Sci (USA) 88: 3033\u20133037.","journal-title":"Proc Natl Acad Sci (USA)"},{"key":"BF6690408_CR74","first-page":"97","volume":"8","author":"R Weide","year":"1994","unstructured":"Weide, R., Tiemann, M., Pfluger, K. H., Koppler, H., Parvizl, B., Wacker, H. H., Kreipe, H. H., Havemann, K. & Parwaresch, M. R. (1994). Altered expression of the retinoblastoma gene-product in human high-grade non-Hodgkins-lymphomas. Leukemia 8: 97\u2013101.","journal-title":"Leukemia"},{"key":"BF6690408_CR75","first-page":"43","volume":"12","author":"RA Weinberg","year":"1992","unstructured":"Weinberg, R. A. (1992). The retinoblastoma gene and gene product. Cancer Surv 12: 43\u201357.","journal-title":"Cancer Surv"},{"key":"BF6690408_CR76","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","volume":"81","author":"RA Weinberg","year":"1995","unstructured":"Weinberg, R. A. (1995). The retinoblastoma protein and cell cycle control. Cell 81: 323\u2013330.","journal-title":"Cell"},{"key":"BF6690408_CR77","first-page":"419","volume":"13","author":"M Welcker","year":"1996","unstructured":"Welcker, M., Lukas, J., Strauss, M. & Bartek, J. (1996). Enhanced protein stability: a novel mechanism of D-type cyclin over abundance identified in human sarcoma cells. Oncogene 13: 419\u2013425.","journal-title":"Oncogene"},{"key":"BF6690408_CR78","first-page":"807","volume":"4","author":"HJ Xu","year":"1989","unstructured":"Xu, H. J., Hu, S. X., Hashimoto, T., Takahashi, R. & Benedict, W. F. (1989). The retinoblastoma susceptibility gene-product \u2013 a characteristic pattern in normal-cells and abnormal expression in malignant cells. Oncogene 4: 807\u2013812.","journal-title":"Oncogene"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690408","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:53:13Z","timestamp":1684414393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4,23]]},"references-count":78,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["BF6690408"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690408","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4,23]]}}}